| Filed On | Filing |
|---|---|
| 14 Apr 2026 |
Form 3: Fox Michael, Chief Operating Officer
No securities owned |
| 12 Sep 2025 |
Form 3: Bonfiglioli Elena, Director
No securities owned |
| 05 Aug 2025 |
Form 3: Theofilos James Charles, Director
Holds 1,391 shares of Common Stock |
| 04 Oct 2024 |
Form 3: Lev Joshua S., Chief Financial Officer
Holds 16,333 shares of Common Stock |
| 18 Dec 2023 |
Form 3: Theofilos Charles Steve, Director
Holds 412,410 shares of Common Stock |
| 16 Mar 2022 |
Form 3: Goldstein Julie Ann, Director
Holds 360,212 shares of Common Stock |
| 16 Mar 2022 |
Form 3: Wilber Patricia, Director
No securities owned |
| 06 Apr 2020 |
Form 3: Cuneo F Peter, Director
No securities owned |
| 06 Apr 2020 |
Form 3: Patton Thomas M, Director
No securities owned |
| 06 Apr 2020 |
Form 3: Gandolfo John P, Director
No securities owned |
| 03 Oct 2019 |
Form 3: Goldberger Daniel S, Director
Holds 0 shares of No securities are beneficially owned. |
| 03 Apr 2019 | Form 3: Posner Brian M, Chief Financial Officer |
| 22 Jun 2018 |
Form 3: Merck Global Health Innovation Fund, Llc, 10% owner
Holds 3,179,366 shares of Common Stock |
| 21 Jun 2018 |
Form 3: Vraniak Glenn S., Chief Financial Officer
Holds 117,835 shares of Common Stock |
| 21 Jun 2018 |
Form 3: Tullis James L L, Director
Holds 111,227 shares of Common Stock |
| 21 Jun 2018 |
Form 3: Staats Peter S., Chief Medical Officer
Holds 144,636 shares of Common Stock |
| 21 Jun 2018 | Form 3: Ondra Stephen, Director |
| 21 Jun 2018 |
Form 3: Moody Trevor J, Director
Holds 37,166 shares of Common Stock |
| 21 Jun 2018 |
Form 3: Errico Thomas J., Director
Holds 456,651 shares of Common Stock |
| 21 Jun 2018 |
Form 3: Errico Joseph P, Director
Holds 632,349 shares of Common Stock |
Loading...